ArticleHead and neck pathology2026
Expanding the Histologic Spectrum of Human Papillomavirus (HPV)-Associated Oropharyngeal Carcinoma: A Retrospective Study of 379 Cases Focusing on Classification, Histologic Features, and their Prognostic Significance.
Article in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe WHO classification includes squamous cell carcinoma (SCC) and neuroendocrine carcinoma as two histotypes of HPV-associated oropharyngeal carcinoma (HPV + OPC). Among SCC, the recognized subtypes include non-keratinizing, keratinizing, papillary, adenosquamous, ciliated adenosquamous, lymphoepithelial, spindle cell, and basaloid subtypes.
designThis retrospective study included 379 consecutive cases of HPV+ OPC resected between 2017 and 2024.
resultsThe morphologies included SCC (83.4%), adenosquamous carcinoma (n=11, 2.9%, including 6 with cilia), combined neuroendocrine carcinoma and SCC (n=3, 0.8%), adenocarcinoma (n=1, 0.3%), and undifferentiated carcinoma (n=1, 0.3%). Among SCC subtypes, the most common was non-keratinizing (n=316), followed by papillary (n=22), lymphoepithelial (n=9), basaloid (matrix-producing, n=9), keratinizing (n=6), and spindle cell (sarcomatoid, n=1). Tumors could display various histologic features, such as papillary architecture (29.2%), lymphoepithelial regions (10.3%), and basaloid (matrix-producing) areas (7.1%). On univariate survival analysis, adverse histologic features included any percentage of glandular differentiation, a basaloid component, extranodal extension (ENE), and low stromal tumor infiltrating lymphocytes (sTIL). Basaloid areas and extranodal extension were independent adverse prognostic factors identified on multivariate survival analysis.
conclusionHerein, we report two histotypes of HPV+ OPC not yet recognized by the WHO classification, being adenocarcinoma and undifferentiated carcinoma. Additionally, multiple adverse histologic features were identified, including basaloid components and ENE as independent prognostic factors. Therefore, recognizing and reporting such features in the pathology report of HPV+ OPC, even when present in minor proportions, is important for risk stratification and clinical management. CLINICAL
trial registrationNot applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.